There are 76 news based on search keyword " pharmaceutical "

Avenacy Reports Strong 2024 Performance, Outlines 2025 Strategic Priorities

KUALA LUMPUR, Jan 7 (Bernama) -- Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, has provided an update on recent business highlights and financial performance for 2024 and outlined its strategic priorities for this year.

Pharmaniaga Records 3Q Net Profit Of RM101.03 Mln

KUALA LUMPUR, Nov 26 (Bernama) -- Pharmaniaga Bhd has recorded a net profit of RM101.03 million in the third quarter (3Q) ended Sept 30, 2024, from a net loss of RM49.34 million in the same period last year.

Cuba Mulls Biotech, Pharma Partnership With Malaysia, Eyeing ASEAN Launchpad

KUALA LUMPUR, Nov 26 (Bernama) -- Cuba and Malaysia should forge deeper partnerships in biotechnology and pharmaceuticals, particularly in producing vaccines, including halal vaccines that would cater to the local demographics, Cuban Ambassador to Malaysia Florentino Batista Gonzalez said.

RM1.24 Bln Potential Export To Peru Generated - PM Anwar

By M. Saraswathi

LIMA (Peru), Nov 16 (Bernama) -- Prime Minister Datuk Seri Anwar Ibrahim's maiden official visit to Peru has generated potential exports worth RM1.24 billion (US$0.3 billion), particularly in high potential sectors on the initiative of the Malaysia External Trade Development Corporation (MATRADE).

BMI Revises Malaysia’s Health Expenditure Growth Forecast To 8.7 Pct

KUALA LUMPUR, Nov 1 (Bernama) -- BMI, a Fitch Solutions company, has revised its forecast for Malaysia’s health expenditure growth to 8.7 per cent per year from 2023 to 2028, up from its previous forecast of 8.3 per cent.

Sweden-Malaysia Economic Ties Flourish, FDI Soars & Semiconductor Sector Emerges As Key Growth Area

KUALA LUMPUR, Nov 1 (Bernama) -- Economic ties between Sweden and Malaysia have flourished over the years, with Swedish foreign direct investment (FDI) in Malaysia soaring to US$1.43 billion (US$1=RM4.37) to date from US$113 million in 2014.

World Halal Awards Put Malaysia On Firm Footing To Reap Global US$5 Trillion Market -- HDC

MELAKA, Oct 30 (Bernama) -- The Halal Development Corporation Bhd’s (HDC) World Halal Excellence Awards 2023 (WHEA 2023), now in its 15th year, complements Malaysia’s halal industry ecosystem, and puts it in a strong position to reap the global halal market opportunities, estimated to reach US$5 trillion by 2030. 

Kolmar BNH Strives For Global Expansions Building On HemoHim's Recognition

KUALA LUMPUR, Oct 22 (Bernama) -- Kolmar BNH immune-boosting health supplement, ‘HemoHim’, has earned international recognition for its quality from both the United States (US) Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace.

Pharma And Healthcare Expo 2024 To Boost Malaysia As Regional Healthcare Hub

KUALA LUMPUR, Oct 18 (Bernama) -- The inaugural Malaysia Pharma and Healthcare Expo 2024 to be held at the Malaysia International Trade and Exhibition Centre (MITEC) from Oct 22-24, is set to boost Malaysia’s healthcare industry by promoting innovative products, fostering partnerships, and attracting investments in medical devices and pharmaceutical products.

More Than 10,000 Jobs To Be Created With Industrial Cluster Development - MITI

KUALA LUMPUR, Oct 17 (Bernama) -- The Investment, Trade and Industry Ministry (MITI) expects 10,380 job opportunities to be created via an industrial cluster development in the central region comprising the Federal Territory of Kuala Lumpur, Selangor, Negeri Sembilan and Melaka.

Pharmaniaga Appoints EY As New External Auditor Effective Oct 9

KUALA LUMPUR, Oct 10 (Bernama) -- Pharmaniaga Bhd (Pharmaniaga) has appointed Ernst & Young (EY) as its new external auditor, effective Oct 9, 2024.

Curia's Refreshed Brand Features Key Capabilities, Personalised Approach Across Service Offerings

KUALA LUMPUR, Oct 8 (Bernama) -- Curia, a contract research, development and manufacturing organisation, has unveiled its refreshed brand highlighting key capabilities and a personalised approach across small molecules, generic active pharmaceutical ingredients (APIs) and biologics.